-
21 provinces have clarified the implementation time of special centralized insulin collection (with national situation)
Time of Update: 2022-08-15
According to the previous schedule, the results of the sixth batch of special centralized procurement of national insulin will be implemented in May 2022. At present, the first-year agreement procure
-
The key tasks of deepening the reform of the medical and health system in 2022 [full text + one picture to understand]
Time of Update: 2022-08-15
(The National Medical Insurance Administration, the Ministry of Finance, the Ministry of Human Resources and Social Security, the National Health Commission, and the State Administration of Traditional Chinese Medicine are responsible according to the division of responsibilities) (8) Promote the reform of medical service prices .
-
The scope of procurement with volume continues to expand, how should multinational pharmaceutical companies respond?
Time of Update: 2022-08-15
▲Source: Digital technology and advanced analytics in Roche, 2020 At this stage, procurement with volume has become a major policy in the pharmaceutical industry, and the strategic transformation of multinational pharmaceutical companies is an inevitable trend.
-
Forbes AI Emerging 50: 6 biotech and pharmaceutical companies on the list
Time of Update: 2022-08-15
Based on these statistical regularities, machine learning systems can generate customized protein therapeutics This technology allows drug developers to develop protein drugs targeting specific targets without relying on trial-and-error high-throughput screening .
-
Exclusive Chinese patent medicine explodes the tens of billions of stomach disease market!
Time of Update: 2022-08-15
With the acceleration of the pace of life, the incidence of gastric diseases is increasing year by year, and Chinese patent medicines for the treatment of gastric diseases are gradually favored by pa
-
DDW 2022 Pfizer, Eli Lilly, Johnson & Johnson Announce Clinical Trial Results of Inflammatory Bowel Disease
Time of Update: 2022-08-15
03 Janssen03 Janssen Johnson & Johnson's Janssen Pharmaceuticals Announces New Data from the Phase 1 GALAXI Trial of TREMFYA ® (guselkumab) in Adult Patients With Moderately to Severely Active Crohn's Disease (CD) and in Ulcers Treated with STLARA ® (ustekinumab) Three independent long-term pooled analyses of adult patients with chronic colitis (UC) and CD .
-
The number of new infections in Beijing has reached a new high in a single day for a whole month. What does this mean?
Time of Update: 2022-08-15
Data source: The official website of the Beijing Municipal Health Commission, from 0-24:00 that day Eight o'clock Jianwen drawing During the month of the epidemic in Beijing, the number of urban areas involved in the epidemic continued to increase, the measures for epidemic prevention and control were gradually increased, and high-frequency large-scale nucleic acid testing continued to be carried out .
-
Where is the future of domestic "post-00s" innovative pharmaceutical companies?
Time of Update: 2022-08-15
Table 1: IPO of some "post-00" pharmaceutical companies According to the public information of the Securities Times , a total of 19 innovative drug companies have successfully landed in the Hong Kong stock market and A-share market in 2021.
-
How to become a dual channel pharmacy?
Time of Update: 2022-08-15
Guangzhou has launched the evaluation of "dual-channel" pharmacies, and will determine the list of "dual-channel" candidate pharmacies based on the comprehensive evaluation ranking and the upper limi
-
In 2021, drug sales of public medical institutions will reach 1,297.3 billion yuan, biological drugs will soar, and domestic substitution will accelerate under the normalization of centralized procurement
Time of Update: 2022-08-15
In 2021, with the gradual easing of the domestic epidemic, China's economy will continue to recover steadily, market demand will rebound, and economic development will be stable and sound . In the ph
-
Focus on anti-tumor and nervous system drugs, what are the FDA-approved drugs in the first quarter?
Time of Update: 2022-08-15
Table 1: FDA-approved BLA biologics in the first quarter of 2022 Data source: China Pharmaceutical Industry Information Center, Pharma ONE intelligent drug big data analysis platform Approved original chemical drugApproved original chemical drug Among the 35 approved NDA drugs, 6 Type1-new molecular entity new drugs are worthy of attention, including 3 anti-tumor and immunomodulatory agents: Vonjo (pairitinib) is an inhibitor of JAK2, IRAK1 and CSF1R.
-
Under the Bear Market, 4 "Survival Modes" for Biotech Companies: Innovation is the Core No matter what
Time of Update: 2022-08-15
Emergent buys Chimerix's smallpox drug; Otsuka cancels CKD licensing deal with Akebia; AbbVie joins Treg track in partnership with Cugene; Apollo comes in for €1 billion deal .
-
First time in 25 years!
Time of Update: 2022-08-15
Patients who achieved complete clearance of skin symptoms maintained clear or near clear skin for an average of 4 months after discontinuation The 52-week long-term efficacy data showed that adult plaque psoriasis patients treated with tapinarof cream achieved durable improvements in efficacy outcomes and quality of life, with no treatment failures .
-
LAG-3, the next outlet?
Time of Update: 2022-08-15
At the LAG3 Targeted Drug Development Summit held in January this year, Paul Moore from MacroGenics said that the PD-1×LAG-3 bispecific antibody Tebotelimab can simultaneously block the growth of a single T cell.
-
Dozens of policy incentives make it difficult to support new pediatric medicines. Where is the difficulty?
Time of Update: 2022-08-15
12 new pediatric drugs show promise for the future12 new pediatric drugs show promise for the future With the approval of the first domestic child-specific expectorant spray last year and the suspension of the clinical trial of BC0335 granules for children's respiratory syncytial virus infection, in recent years, both the approval and the development of clinical trials in the field of pediatric medicine have been subject to frequent policy changes.
-
Overview of Drug Administration Policies "The 14th Five-Year Plan for Drug Supervision Network Security and Informatization Construction" issued
Time of Update: 2022-08-15
Recently, the State Food and Drug Administration issued the "14th Five-Year Plan for Drug Regulatory Network Security and Informatization Construction" . The "Plan" is formulated in accordance with t
-
Express creates multiple firsts!
Time of Update: 2022-08-15
Today, Caribou Biosciences announced that its CRISPR-based gene editing-engineered ready-to-use CAR-T therapy CB-010 has achieved positive results in a Phase 1 clinical trial in patients with relapsed/refractory B-cell non-Hodgkin lymphoma .
-
"Divine Magazine" CA heavy review: ADC's status quo, challenges, opportunities and future
Time of Update: 2022-08-15
HER2-positive breast cancer , HER2-positive gastric cancer , triple-negative breast cancer, urothelial cancer , cervical cancer Antitumor activity of ADCsAntitumor activity of ADCs To date, the expression of HER2, Trop-2, nectin-4, and a variety of other antigens have been described in multiple tumor types, leading to the hypothesis that ADCs targeting these antigens could achieve broad -spectrum implementation in solid tumors.
-
Global tumor new drug research and development report released!
Time of Update: 2022-08-15
IQVIA released its 2021 Global Oncology Trends Report, which showed that 30 new oncology drugs were approved globally this year, while a total of 104 new anti-cancer drugs were launched globally in 2021, a record high in the past five years.
-
The Age of Nucleic Acid for All and Our Reshaped Life
Time of Update: 2022-08-15
On May 9, Vice Premier Sun Chunlan of the State Council It is pointed out that large cities have established nucleic acid "sampling circles" with a 15-minute walk, and each place has implemented normalized prevention and control measures .
